178 related articles for article (PubMed ID: 17638070)
21. [Effects of estrogen receptor beta on proliferation of ovarian clear cell adenocarcinoma ES-2 in vitro and in vivo].
Zhu J; Feng YJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):588-91. PubMed ID: 17181966
[TBL] [Abstract][Full Text] [Related]
22. Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells?
Scherbakov AM; Lobanova YS; Shatskaya VA; Onopchenko OV; Gershtein ES; Krasil'nikov MA
Breast Cancer Res Treat; 2006 Nov; 100(1):1-11. PubMed ID: 16990991
[TBL] [Abstract][Full Text] [Related]
23. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
[TBL] [Abstract][Full Text] [Related]
24. HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression.
Huang X; Gao L; Wang S; Lee CK; Ordentlich P; Liu B
Cancer Res; 2009 Nov; 69(21):8403-11. PubMed ID: 19826038
[TBL] [Abstract][Full Text] [Related]
25. Unliganded estrogen receptor-beta regulation of genes is inhibited by tamoxifen.
Levy N; Paruthiyil S; Zhao X; Vivar OI; Saunier EF; Griffin C; Tagliaferri M; Cohen I; Speed TP; Leitman DC
Mol Cell Endocrinol; 2010 Feb; 315(1-2):201-7. PubMed ID: 19744542
[TBL] [Abstract][Full Text] [Related]
26. Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.
Skliris GP; Lewis A; Emberley E; Peng B; Weebadda WK; Kemp A; Davie JR; Shiu RP; Watson PH; Murphy LC
Breast Cancer Res Treat; 2007 Jul; 104(1):75-85. PubMed ID: 17009105
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of estrogen receptor beta in breast cancer.
Saji S; Hirose M; Toi M
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():21-6. PubMed ID: 16273360
[TBL] [Abstract][Full Text] [Related]
28. The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment.
Marcsek Z; Kocsis Z; Jakab M; Szende B; Tompa A
Cancer Biother Radiopharm; 2004 Dec; 19(6):746-53. PubMed ID: 15665622
[TBL] [Abstract][Full Text] [Related]
29. Effects of tetramethoxystilbene on hormone-resistant breast cancer cells: biological and biochemical mechanisms of action.
Park H; Aiyar SE; Fan P; Wang J; Yue W; Okouneva T; Cox C; Jordan MA; Demers L; Cho H; Kim S; Song RX; Santen RJ
Cancer Res; 2007 Jun; 67(12):5717-26. PubMed ID: 17575138
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens.
Coradini D; Pellizzaro C; Speranza A; Daidone MG
Cell Mol Life Sci; 2004 Jan; 61(1):76-82. PubMed ID: 14704855
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor beta in breast cancer--diagnostic and therapeutic implications.
Hartman J; Ström A; Gustafsson JA
Steroids; 2009 Aug; 74(8):635-41. PubMed ID: 19463683
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells.
Treeck O; Pfeiler G; Mitter D; Lattrich C; Piendl G; Ortmann O
J Endocrinol; 2007 Jun; 193(3):421-33. PubMed ID: 17535880
[TBL] [Abstract][Full Text] [Related]
33. Loss of tumourigenicity of stably ERbeta-transfected MCF-7 breast cancer cells.
Behrens D; Gill JH; Fichtner I
Mol Cell Endocrinol; 2007 Aug; 274(1-2):19-29. PubMed ID: 17597290
[TBL] [Abstract][Full Text] [Related]
34. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development.
Park BW; Kim KS; Heo MK; Yang WI; Kim SI; Kim JH; Kim GE; Lee KS
J Surg Oncol; 2006 May; 93(6):504-10. PubMed ID: 16615154
[TBL] [Abstract][Full Text] [Related]
35. [Effects of tamoxifen on apoptosis and matrix metalloproteinase-7 expression in estrogen receptor beta-positive colonic cancer cell line HT-29].
Fang YJ; Wang GQ; Lu ZH; Zhang LY; Pan ZZ; Zhou ZW; Wan DS
Ai Zheng; 2008 Nov; 27(11):1172-6. PubMed ID: 19000448
[TBL] [Abstract][Full Text] [Related]
36. Evidence that estrogen receptor beta enhances MMP-13 promoter activity in HIG-82 cells and that this enhancement can be influenced by ligands and involves specific promoter sites.
Lu T; Achari Y; Rattner JB; Hart DA
Biochem Cell Biol; 2007 Jun; 85(3):326-36. PubMed ID: 17612627
[TBL] [Abstract][Full Text] [Related]
37. Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.
Lattrich C; Juhasz-Boess I; Ortmann O; Treeck O
Oncol Rep; 2008 Mar; 19(3):811-7. PubMed ID: 18288420
[TBL] [Abstract][Full Text] [Related]
38. Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis.
Cheng J; Lee EJ; Madison LD; Lazennec G
FEBS Lett; 2004 May; 566(1-3):169-72. PubMed ID: 15147889
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor beta (ERbeta) and inhibition of prostate cancer cell proliferation: studies on the possible mechanism of action in DU145 cells.
Pravettoni A; Mornati O; Martini PG; Marino M; Colciago A; Celotti F; Motta M; Negri-Cesi P
Mol Cell Endocrinol; 2007 Jan; 263(1-2):46-54. PubMed ID: 17023111
[TBL] [Abstract][Full Text] [Related]
40. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation.
Jawed S; Kim B; Ottenhof T; Brown GM; Werstiuk ES; Niles LP
Eur J Pharmacol; 2007 Mar; 560(1):17-22. PubMed ID: 17303109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
